Marc Breton
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Marc Breton sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Marc Breton: 6 sponsored US clinical trials, none currently recruiting.
Marc Breton sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. The most-studied condition in this pipeline is Type 1 Diabetes, with 2 trials.
Upper-quartile sponsor footprint
Marc Breton sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Safety and Feasibility Testing of a Smaller Network Version of AIDANET
NCT06633965
The Pediatric Artificial Pancreas Automated Initialization Trial
NCT06017089
Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery
NCT05528770
The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes
NCT04796779
Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas
NCT03859401
Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator
NCT01945060
Therapeutic Areas
How the Marc Breton archive is shaped
6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Type 1 Diabetes (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Marc Breton: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Marc Breton sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Marc Breton page
6 registered trials is a research-attention snapshot, not an endorsement of Marc Breton or any single study.
- None of Marc Breton's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Type 1 Diabetes is the condition Marc Breton studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Marc Breton pipeline card: 6 registered trials from official public datasets.Report a data error.